Needham Maintains Buy on Veracyte, Lowers Price Target to $27
Needham Maintains Buy on Veracyte, Lowers Price Target to $27
Needham維持對Veracyte的買入,將目標股價下調至27美元
Needham analyst Mike Matson maintains Veracyte (NASDAQ:VCYT) with a Buy and lowers the price target from $33 to $27.
尼德姆分析師邁克·馬特森維持Veracyte(納斯達克股票代碼:VCYT)的買入並將目標股價從33美元下調至27美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。